Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$24.46 USD
-0.03 (-0.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.43 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Mirum Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 |
Depreciation/Amortization & Depletion | 11.95 | 3.68 | 0.98 | 0.70 | 0.00 |
Net Change from Assets/Liabilities | -22.64 | -21.05 | 16.98 | 0.61 | 7.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 103.17 | 32.90 | -66.73 | 12.89 | 6.07 |
Net Cash From Operating Activities | -70.94 | -120.14 | -132.76 | -89.08 | -39.36 |
Property & Equipment | -0.11 | -0.28 | -0.02 | -0.23 | -0.28 |
Acquisition/ Disposition of Subsidiaries | -212.76 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 125.67 | 7.98 | -40.43 | 38.10 | -127.50 |
Other Investing Activities | -20.00 | 0.00 | 89.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -107.20 | 7.70 | 48.55 | 37.87 | -127.78 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 227.15 | 114.64 | 9.01 | 131.87 | 127.18 |
Issuance (Repayment) of Debt | 305.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -195.86 | -5.55 | 64.45 | 49.42 | 0.00 |
Net Cash from Financing Activities | 336.60 | 109.09 | 73.47 | 181.29 | 127.18 |
Effect of Exchange Rate Changes | -0.13 | 0.01 | 0.00 | 0.03 | -0.03 |
Net Change In Cash & Equivalents | 158.32 | -3.34 | -10.75 | 130.12 | -39.99 |
Cash at Beginning of Period | 128.00 | 131.34 | 142.09 | 11.97 | 51.96 |
Cash at End of Period | 286.33 | 128.00 | 131.34 | 142.09 | 11.97 |
Diluted Net EPS | -4.00 | -4.02 | -2.77 | -4.09 | -4.58 |
Fiscal Year End for Mirum Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -163.42 | -127.76 | -104.17 | -30.13 |
Depreciation/Amortization & Depletion | NA | 11.95 | 6.05 | 2.98 | 1.48 |
Net Change from Assets/Liabilities | NA | -22.64 | -11.77 | -6.13 | -17.63 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 103.17 | 79.15 | 71.21 | 12.51 |
Net Cash From Operating Activities | NA | -70.94 | -54.33 | -36.11 | -33.77 |
Property & Equipment | NA | -0.11 | -0.11 | -0.11 | -0.04 |
Acquisition/ Disposition of Subsidiaries | NA | -212.76 | -212.76 | 0.00 | 0.00 |
Investments | NA | 125.67 | 122.67 | 92.67 | 42.06 |
Other Investing Activities | NA | -20.00 | -15.00 | -15.00 | 0.00 |
Net Cash from Investing Activities | NA | -107.20 | -105.20 | 77.56 | 42.02 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 227.15 | 225.10 | 17.97 | 15.87 |
Issuance (Repayment) of Debt | NA | 305.30 | 305.30 | 305.30 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -195.86 | -195.58 | -195.58 | -2.88 |
Net Cash from Financing Activities | NA | 336.60 | 334.82 | 127.69 | 12.99 |
Effect of Exchange Rate Changes | NA | -0.13 | -0.24 | 0.07 | 0.19 |
Net Change In Cash & Equivalents | NA | 158.32 | 175.06 | 169.23 | 21.42 |
Cash at Beginning of Period | NA | 128.00 | 128.00 | 128.00 | 128.00 |
Cash at End of Period | NA | 286.33 | 303.06 | 297.23 | 149.42 |
Diluted Net EPS | NA | -0.69 | -0.57 | -1.94 | -0.80 |